PayaVax G7

PayaVax G-VII is an inactivated monovalent vaccine developed to provide immunity in poultry against highly virulent Newcastle Disease caused by Genotype G-VII. This vaccine is produced using a local virus strain and manufactured in compliance with international standards, including GMP (Good Manufacturing Practices) guidelines. Effective immunity Flexible application Long-lasting protection Manufactured according to international standards Approved by the Iranian Veterinary Organization

Indications

PayaVax G-VII is used to induce immunity in poultry, including broilers, breeders, and layers, against Newcastle Disease caused by Genotype G-VII.

Dosage and Administration

For birds under 3 weeks of age: 0.2 mL per bird via subcutaneous injection
For birds over 3 weeks of age: 0.5 mL per bird via intramuscular or subcutaneous injection
Under 4 weeks: 0.5 mL per bird via subcutaneous injection
Over 4 weeks: 1.5 mL per bird via subcutaneous or intramuscular injection

Instructions for Use

Remove the vaccine vial from the refrigerator and allow it to reach room temperature.
Carefully read the provided instructions.
Shake the vial thoroughly several times to ensure a homogeneous solution, then draw it into the syringe.

Active Ingredient

Highly virulent Newcastle Disease Virus, Genotype G7, isolated from a local Iranian strain (NDV-GVII)
10⁸ EID₅₀ / Dose